Aman Bhatti

Cumulus Neuroscience Ltd. is a company based in Belfast, Ireland. The Irish company achieves this through the use of machine learning analytics and the world's largest database of annotated, longitudinal, neurofunctional data. Cumulus Neuroscience aims to generate the data and insights necessary to accelerate the diagnosis and management of central nervous system disorders. The company's AI-based, multi-domain digital biomarker platform enables better and faster decision-making in neurology and neuropsychiatry clinical trials and patient care. Cumulus Neuroscience Ltd. is supported by specialized investors and has a world-class scientific and technical advisory board. The company, founded by Ronan Cunningham, Ruth McKernan, Brian Murphy, Sigurdur Sævarsson, and Urs Markus Ernst Streidl, is focused on simplifying and improving the robustness of neuroscience clinical trials. Aman Bhatti has been the CEO of the company since 2022.

Cumulus Neuroscience Ltd. is a company based in Belfast, Ireland. The Irish company achieves this through the use of machine learning analytics and the world's largest database of annotated, longitudinal, neurofunctional data. Cumulus Neuroscience aims to generate the data and insights necessary to accelerate the diagnosis and management of central nervous system disorders. The company's AI-based, multi-domain digital biomarker platform enables better and faster decision-making in neurology and neuropsychiatry clinical trials and patient care. Cumulus Neuroscience Ltd. is supported by specialized investors and has a world-class scientific and technical advisory board. The company, founded by Ronan Cunningham, Ruth McKernan, Brian Murphy, Sigurdur Sævarsson, and Urs Markus Ernst Streidl, is focused on simplifying and improving the robustness of neuroscience clinical trials. Aman Bhatti has been the CEO of the company since 2022.

Cumulus Neuroscience Ltd. is a company based in Belfast, Ireland. The Irish company achieves this through the use of machine learning analytics and the world's largest database of annotated, longitudinal, neurofunctional data. Cumulus Neuroscience aims to generate the data and insights necessary to accelerate the diagnosis and management of central nervous system disorders. The company's AI-based, multi-domain digital biomarker platform enables better and faster decision-making in neurology and neuropsychiatry clinical trials and patient care. Cumulus Neuroscience Ltd. is supported by specialized investors and has a world-class scientific and technical advisory board. The company, founded by Ronan Cunningham, Ruth McKernan, Brian Murphy, Sigurdur Sævarsson, and Urs Markus Ernst Streidl, is focused on simplifying and improving the robustness of neuroscience clinical trials. Aman Bhatti has been the CEO of the company since 2022.

Cumulus Neuroscience Ltd. is a company based in Belfast, Ireland. The Irish company achieves this through the use of machine learning analytics and the world's largest database of annotated, longitudinal, neurofunctional data. Cumulus Neuroscience aims to generate the data and insights necessary to accelerate the diagnosis and management of central nervous system disorders. The company's AI-based, multi-domain digital biomarker platform enables better and faster decision-making in neurology and neuropsychiatry clinical trials and patient care. Cumulus Neuroscience Ltd. is supported by specialized investors and has a world-class scientific and technical advisory board. The company, founded by Ronan Cunningham, Ruth McKernan, Brian Murphy, Sigurdur Sævarsson, and Urs Markus Ernst Streidl, is focused on simplifying and improving the robustness of neuroscience clinical trials. Aman Bhatti has been the CEO of the company since 2022.

Cumulus Neuroscience Ltd. is a company based in Belfast, Ireland. The Irish company achieves this through the use of machine learning analytics and the world's largest database of annotated, longitudinal, neurofunctional data. Cumulus Neuroscience aims to generate the data and insights necessary to accelerate the diagnosis and management of central nervous system disorders. The company's AI-based, multi-domain digital biomarker platform enables better and faster decision-making in neurology and neuropsychiatry clinical trials and patient care. Cumulus Neuroscience Ltd. is supported by specialized investors and has a world-class scientific and technical advisory board. The company, founded by Ronan Cunningham, Ruth McKernan, Brian Murphy, Sigurdur Sævarsson, and Urs Markus Ernst Streidl, is focused on simplifying and improving the robustness of neuroscience clinical trials. Aman Bhatti has been the CEO of the company since 2022.